SummaryAn in vitro damage-repair model by irradiation of primary intestinal epithelial cells was established and validated. This identified hepatocyte nuclear factor 4α as a regulator of intestinal repair. In vivo knockout of *Hnf4a* confirmed its crucial role in the regeneration process.

The barrier that separates our body from the intestinal content consists of a single layer of polarized epithelial cells, covered by a thin layer of mucus. To maintain its integrity and ward off colonization by potentially harmful microbes,[@bib1] the homeostatic intestinal epithelium is renewed continuously from a pool of stem cells. When damaged, the epithelium has a remarkable ability for repair. For example, we and others have found that when almost all stem cells are lost from the intestinal epithelium of a mouse by an induced genetic mutation, it takes only approximately 72 hours for the epithelial layer to entirely repopulate from the few wild-type cells that have escaped genetic recombination.[@bib2]^,^[@bib3] The mechanisms that underlie that remarkable plasticity of the epithelial layer have not been fully defined.

The important role of the epithelial barrier in health and disease has been underscored by recent findings that it has a pathophysiological relevance well beyond intestinal diseases such as inflammatory bowel disease. It has become increasingly clear that a defective epithelial barrier can predispose to a wide range of extraintestinal diseases such as steatohepatitis,[@bib4] IgA nephropathy,[@bib5] and systemic lupus erythematosus.[@bib6] The mechanisms that maintain epithelial barrier function and facilitate its repair therefore have become of broader relevance to therapeutic interventions in human disease than the traditional narrow focus of intestinal disease.

To study intestinal epithelial regeneration, various mouse models have been developed. The most frequently used model induces intestinal epithelial injury by whole-body exposure to ionizing radiation.[@bib7] The response to irradiation has been well characterized in mice and is used to asses clonogenic capacity of intestinal epithelial stem cells.[@bib8] Radiation damage initiates a variety of cellular stress responses that result in widespread cell-cycle arrest and apoptosis, especially in rapidly proliferating stem cells in the intestinal crypts.[@bib9] A radiation dose of 14 Gy is sufficient to deplete most of the epithelial stem cells of the intestine and results in the loss of the majority of intestinal crypts, compromising mucosal integrity.[@bib9]^,^[@bib10] This widespread epithelial damage rapidly induces a process of epithelial repair from surviving crypts. This regenerative response becomes morphologically apparent after approximately 72 hours with increased epithelial proliferation in hyperplastic surviving crypts and crypt multiplication through a process of fissioning and bifurcation.[@bib11]^,^[@bib12]

Intestinal epithelial wounding and repair often has been studied in vitro using monolayers of colorectal cancer cells that are disrupted with the tip of a pipette, so-called *scratch assays*. The physiological relevance of these models, which perhaps depend more on epithelial cell migration by proliferating cancer cells than a stem cell--driven repair process, is unknown. Recently, in vitro culture methods have been developed that allow the generation and expansion of 3-dimensional intestinal organoids from primary intestinal epithelial cells.[@bib13] Organoids show all major hallmarks of the architecture of the intestinal epithelium, including crypt and villus domains and the presence of all epithelial cell lineages.[@bib13] With standard 3-dimensional culture conditions, organoids continuously are expanding in size and number of crypts, as such, they are sometimes believed to be more reflective of an epithelium in a state of repair than a truly homeostatic epithelial layer. The use of such organoids of primary epithelial cells in a model of damage and repair may provide a more physiological in vitro model than has been used previously. Such a model may provide a platform to dissect the mechanisms that regulate epithelial repair and identify novel therapeutic targets.

Damage models using organoid culture exposed to irradiation have been developed previously, however, the recovery phase after induction of damage was not characterized extensively.[@bib14], [@bib15], [@bib16], [@bib17] Here, we performed a dose range of γ-radiation on intestinal epithelial organoids to identify a sublethal dose that results in a cycle of damage and repair, as measured by the loss and resurgence of expression of intestinal epithelial stem cell markers such as leucine-rich repeat-containing G-protein--coupled receptor 5 (*Lgr5*) and olfactomedin 4 (*Olfm4*), as well as morphologic characteristics. Transcriptomic analysis of different time points identified hepatocyte nuclear factor 4α (HNF4α) as one of the upstream regulators of the epithelial response to damage. In vitro experiments using *Hnf4a* mutant organoids, as well as in vivo experiments using epithelium-specific *Hnf4a* mutant mice, showed a critical role for HNF4α in organoid expansion after seeding as well as epithelial repair after irradiation in vivo. Thus, we established a primary epithelial cell--based in vitro model of damage and repair that successfully identified a novel transcriptional regulator of epithelial repair.

Results {#sec1}
=======

Irradiation-Induced Damage and Repair of Intestinal Organoids {#sec1.1}
-------------------------------------------------------------

To probe whether the regenerative response of the intestinal epithelium is maintained in vitro, we irradiated adult intestinal organoid cultures on day 3 after splitting. At this time point, organoids have established clear crypt-like buds. To titrate the optimal irradiation dose necessary to cause sublethal damage and subsequent repair, we exposed organoids to various doses of y-radiation ranging from 1 to 10 Gy. Doses of irradiation less than 6 Gy did not visibly affect organoid growth. However, we noted a dose-dependent reduction in organoid survival starting at 6 Gy, and a complete organoid loss at 10 Gy. Moreover, at 6 Gy we observed initial loss of organoid buds with subsequent bud regeneration ([Figure 1](#fig1){ref-type="fig"}*A* and *B*). Based on these observations, we chose 6 Gy as the dose for further detailed analyses. We next analyzed the expression of stem cell markers *Lgr5* and *Olfm4* using quantitative reverse-transcription polymerase chain reaction (qRT-PCR) at different time points after 6 Gy exposure. In line with the observed loss of organoid buds and subsequent regrowth, expression of both *Lgr5* and *Olfm4* was reduced significantly 24 hours after 6 Gy irradiation, and completely recovered at 96 hours for *Lgr5* ([Figure 1](#fig1){ref-type="fig"}*C*). Interestingly, expression levels of *Olfm4* increased to 3-fold greater than the expression at baseline ([Figure 1](#fig1){ref-type="fig"}*C*), similarly to what has been described in vivo.[@bib18]Figure 1**An in vitro model of intestinal damage and repair using 6 Gy irradiation on intestinal organoids.** (*A*) Bright-field time series of intestinal organoids 24, 48, 72, and 96 hours after 0, 1, 2, 4, 6, 8, and 10 Gy γ-irradiation. *Scale bar*: 100 μm. (*B*) Relative amount of buds at 0, 24, 48, 72, and 96 hours (compared with t = 0 hours) after 0, 1, 2, 4, 6, 8, and 10 Gy γ-irradiation. Representative of 2 independent experiments. Average of 44 organoids quantified per condition and time point. (*C*) Relative gene expression of stem cell markers *Lgr5* and *Olfm4* after 6 Gy irradiation compared with nonirradiated controls (n = 3). *Gapdh* is used as a reference gene. Data were obtained in 3 independent experiments and plotted as means ± SEM. ∗*P* \< .05, ∗∗*P* \< .01, and ∗∗∗*P* \< .001 compared with nonirradiated control calculated by 1-way analysis of variance. (*D*) Apoptosis and (*E*) cell proliferation assessment by means of Annexin V staining and EdU incorporation flow cytometry analysis (n = 3). Data are plotted as means ± SEM. ∗∗∗*P* \< .001 and ∗∗∗∗*P* \< .0001 compared with nonirradiated time point--matched control calculated by 1-way analysis of variance. mRNA, messenger RNA.

To further characterize the response to 6 Gy irradiation, we evaluated cell apoptosis and proliferation during the damage--repair process by flow cytometry analysis. Apoptosis was highest at 24 hours after irradiation and was increased compared with the nonirradiated time point--matched control organoids at all time points, as assessed by both annexin V and propidium iodide staining ([Figure 1](#fig1){ref-type="fig"}*D*). On the other hand, the number of cells in S phase initially was reduced at 24 hours and then increased over time. At 96 hours after irradiation, proliferation was enhanced markedly, mirroring the timing of maximal epithelial proliferation observed after irradiation in vivo ([Figure 1](#fig1){ref-type="fig"}*E*). Together, these findings suggest that 6 Gy is a sufficient dose of irradiation to cause substantial damage in intestinal epithelial organoids, while retaining their regenerative potential. Moreover, we found that hallmarks of the in vivo regenerative response were recapitulated in irradiated organoids in vitro.

Transcriptomic Analysis Identified HNF4α as an Upstream Regulator of the Regenerative Response In Vitro {#sec1.2}
-------------------------------------------------------------------------------------------------------

To investigate the transcriptional regulation of the regenerative epithelial response, we determined global gene expression changes by microarray analysis. As organoids undergo dynamic growth within the culture, we controlled each time point after irradiation to nonirradiated organoids grown in culture for the same time. Global expression profiling showed that the main transcriptional changes occurred at 24 and 48 hours after irradiation. At these time points we observed a clear separation of the irradiated cultures from matched nonirradiated cultures ([Figure 2](#fig2){ref-type="fig"}*A* and *B*). Remarkably, nonhierarchical clustering showed that the gene expression profile of the organoids at 96 hours after irradiation was highly similar transcriptionally to matched nonirradiated organoids, indicating almost complete organoid recovery within 96 hours ([Figure 2](#fig2){ref-type="fig"}*B*).Figure 2**Gene expression array identifies HNF4α as a potential upstream regulator of intestinal repair.** (*A*) T-distributed stochastic neighbor embedding plot and (*B*) hierarchical clustering analysis of gene expression data from irradiated and time point--matched nonirradiated intestinal organoids at 24, 48, and 96 hours after 6 Gy irradiation (n = 4). (*C*) Differentially regulated pathways, (*D*) cellular functions, and (*E*) regulating transcription factors as determined by Ingenuity pathway analysis (IPA). (*F*) Predicted HNF4α target genes in organoids at 24 hours after 6 Gy irradiation from IPA. (*G*) Differential expression of HNF4α target genes was confirmed by qRT-PCR. Bars represent relative messenger RNA (mRNA) expression of organoids at 24 hours after irradiation compared with nonirradiated organoids (n = 3). Data were obtained from 3 independent experiments and plotted as means ± SEM. ∗*P* \< .05, ∗∗*P* \< .01, and ∗∗∗*P* \< .001 as calculated by the Student *t* test. IL, interleukin; LPS, lipopolysaccharide; TGF, transforming growth factor.

We subsequently used ingenuity pathway analysis (IPA), which showed that gene networks involved in apoptosis (P53--dependent), complement, inflammatory responses (eg, TNF-α signaling via NF-κB), apical junction, tissue restitution, and remodeling (eg, epithelial--mesenchymal transition) were activated in irradiated organoids at 24 and 48 hours vs time point--matched nonirradiated controls ([Figure 2](#fig2){ref-type="fig"}*C* and *D*).

We then used IPA to determine the upstream regulators of cellular processes associated with the irradiation response in organoids. One of the main upstream regulators predicted by IPA was tumor protein 53(P53), a key regulator of the DNA damage response to ionizing radiation, confirming the approach to identify upstream regulators ([Figure 2](#fig2){ref-type="fig"}*E*).[@bib19] In addition, other known regulators of radiation damage such as nuclear protein 1 (NUPR1), lysine-specific demethylase 5B (KDM5B), SMARCA4, and Forkhead box protein M1 (FOXM1) were on the list of upstream regulators.[@bib20], [@bib21], [@bib22], [@bib23] Besides these established transcriptional regulators of radiation damage, the analysis predicted transcription factor HNF4α as one of the top upstream regulators of the response to irradiation ([Figure 2](#fig2){ref-type="fig"}*E* and *F*). Subsequent qRT-PCR analysis of organoid samples 24 hours after irradiation confirmed the expression changes of HNF4α-regulated genes ([Figure 2](#fig2){ref-type="fig"}*G*). As previously described, HNF4α is expressed mainly in the intestinal epithelium.[@bib24] Together these results suggested that HNF4α may be a novel regulator of epithelial repair.

HNF4α Is Required for Organoid Establishment and Propagation In Vitro {#sec1.3}
---------------------------------------------------------------------

To examine the functional role of HNF4α in epithelial repair, we tried to isolate and culture intestinal epithelial cells from mice in which *Hnf4a* specifically was deleted from the intestinal epithelium, using a constitutively expressed epithelial Cre enzyme (*Villin*Cre^*+*^*Hnf4a*^*fl/fl*^ mice) and littermate controls. Interestingly, we were unable to generate organoids from *Hnf4a* mutant epithelium ([Figure 3](#fig3){ref-type="fig"}*A*). Because the seeding of isolated epithelial cells to form organoids mimics the process of damage and repair in many ways, this could fit well with a key role for HNF4α in epithelial repair. To further examine this, we then isolated intestinal epithelial cells from mice in which an intestinal epithelium--specific Cre enzyme could be activated inducibly by treatment with tamoxifen (*Villin*Cre^***+***^ERT2^+^*Hnf4a*^*fl/fl*^ mice) and used organoids from Cre-negative littermates as controls. Noninduced *Villin*Cre^***+***^ERT2^+^*Hnf4a*^*fl/fl*^ grew similar to controls. However, similar to epithelial cells derived from the constitutive *Hnf4a* mutant epithelium, inducible deletion of *Hnf4a* upon exposure to tamoxifen resulted in a failure to propagate organoids in culture, whereas growth of Cre-negative organoids exposed to tamoxifen was unremarkable ([Figure 3](#fig3){ref-type="fig"}*B*, upper panel). These results suggest that HNF4α plays a vital role in establishing organoids from clusters of broken up epithelial cells in the process of organoid damage and reseeding during organoid passaging.Figure 3**HNF4α is essential for intestinal organoid growth.** (*A*) Bright-field microscopic images of wild-type and *Villin*Cre-*Hnf4a*^fl/fl^ small-intestinal crypts and (*B*) tamoxifen-induced *Villin*CreERT2^-^-*Hnf4a*^fl/fl^ and *Villin*CreERT2^+^-*Hnf4a*^fl/fl^ organoids 6 days after tamoxifen induction with and without Wnt3A supplementation. Representative images are shown. *Scale bars*: 250 μm. (*C*) Quantification of the amount of organoids in tamoxifen-inducible *Hnf4a* mutant organoids with and without Wnt3A supplementation at 1 and 7 days after tamoxifen treatment (n = 4). (*D*) Organoids were passaged 7 days after tamoxifen treatment, and the amount of surviving organoids was quantified on days 1 and 4 after passaging (n = 4). Data are plotted as means ± SEM. ∗∗∗*P* \< .001 as calculated by 2-way analysis of variance. Representative images are shown. W-ENR, epidermal growth factor, Noggin, and R-spondin supplemented with Wnt3A.

We next attempted to rescue tamoxifen-treated *Hnf4a*-deficient organoids by supplementing medium with Wnt3A-conditioned medium, which promotes intestinal stem cell survival.[@bib25] One day after Cre induction, the medium in all groups was refreshed with either standard medium containing epidermal growth factor, Noggin, and R-spondin (ENR), or ENR supplemented with Wnt3A ([Figure 3](#fig3){ref-type="fig"}*B*, lower panel). At 7 days after induction, only 50% of the *Hnf4a*-deficient organoids survived without supplementation of Wnt3A ([Figure 3](#fig3){ref-type="fig"}*C*). Surviving organoids appeared to have more cell death and debris in their lumen than *Hnf4a*-expressing control organoids ([Figure 3](#fig3){ref-type="fig"}*B*). On the other hand, when the organoid medium was supplemented with Wnt3A, almost all *Hnf4a*-deficient organoids were able to survive with a similar proliferation rate compared with controls ([Figure 3](#fig3){ref-type="fig"}*C*). However, when they subsequently were passaged, the *Hnf4a*-deficient organoids showed a drastic decrease in viability that could not be recovered by Wnt3A supplementation ([Figure 3](#fig3){ref-type="fig"}*D*). Perhaps supplementation with other growth factors could increase viability of *Hnf4a* knockout organoids at subsequent passages. In conclusion, although Wnt3A supplementation partially can rescue established organoids in which *Hnf4a* is deleted, this is insufficient to rescue epithelial cell death after passaging. These experiments establish a key role for HNF4α during organoid establishment and in organoid regeneration after passaging.

HNF4α Is Required for Intestinal Epithelial Regeneration In Vivo {#sec1.4}
----------------------------------------------------------------

To study the role of HNF4α in intestinal regeneration in vivo, we examined epithelial repopulation after irradiation in mice in which *Hnf4a* was deleted in the intestinal epithelium (*Villin*CreERT2^*+*^*Hnf4a*^*fl/fl*^) using injections with tamoxifen and in tamoxifen-treated Cre-negative littermate control mice (*Villin*CreERT2^*-*^*Hnf4a*^*fl/fl*^). All mice received 14 Gy whole-body irradiation and were euthanized after 96 hours ([Figure 4](#fig4){ref-type="fig"}*A*). Recombination efficiency was assessed by HNF4α immunohistochemistry and showed complete absence of HNF4α protein in the epithelial layer of tamoxifen-treated *Villin*CreERT2^+^*Hnf4a*^*fl/fl*^ mice ([Figure 4](#fig4){ref-type="fig"}*B*). Between 48 and 96 hours after irradiation, the intestinal epithelium was in a regenerative state, characterized by enlarged hyperproliferative crypts ([Figure 4](#fig4){ref-type="fig"}*C*, left panel). We observed that the control animals showed a significantly higher amount of hyperproliferative crypts compared with *Hnf4a*-deficient animals ([Figure 4](#fig4){ref-type="fig"}*C* and *D*). When the number of proliferating cells was examined using immunohistochemistry for bromodeoxyuridine (BrdU), we also observed that the number of proliferating cells per surviving crypt was reduced substantially versus the number of proliferating cells in surviving wild-type crypts ([Figure 4](#fig4){ref-type="fig"}*E* and *F*). Quantification of apoptotic cells by terminal deoxynucleotidyl transferase--mediated deoxyuridine triphosphate nick-end labeling (TUNEL) staining did not show a difference in the overall number of apoptotic cells ([Figure 4](#fig4){ref-type="fig"}*G* and *H*). Together these data suggest that HNF4α plays an important role in crypt survival and proliferating cell survival after irradiation in vivo.Figure 4**HNF4α is required for epithelial regeneration after irradiation in vivo.** (*A*) Schematic overview of the mouse model: *Villin*CreERT2^-^-*Hnf4a*^fl/fl^ and *Villin*CreERT2^+^-*Hnf4a*^fl/fl^ mice were injected with tamoxifen for 5 consecutive days. One week after the final injection, both groups received 14 Gy whole-body irradiation and were killed 96 hours after treatment (n = 8 and 10 per group). (*B*) Immunostaining for HNF4α in small-intestinal tissue at 96 hours after irradiation. (*C*) H&E of small-intestinal tissue at 96 hours after irradiation. (*D*) Quantification of hyperproliferative crypts per visual field. (*E*) BrdU staining of small-intestinal tissue at 96 hours after irradiation. (*F*) Quantification of BrdU-positive cells per crypt. (*G*) TUNEL staining in small-intestinal tissue at 96 hours after irradiation. (*H*) Quantification of TUNEL-positive cells per visual field. n = 8 and 10 per group. Mean values are shown, 1 dot represents 1 mouse. ∗∗∗∗*P* \< .0001 as calculated by the Student *t* test. Slides were counterstained with hematoxylin. *Scale bars*: 50 μm. Representative images are shown.

We examined the expression of stem cell markers *Lgr5* and *Olfm4* using either in situ hybridization or qRT-PCR. We did not observe any difference in *Lgr5* expression between control and *Hnf4a*-deficient animals using either in situ hybridization or qPCR ([Figure 5](#fig5){ref-type="fig"}*A* and *B*). Interestingly, *Olfm4* expression was abrogated almost completely in *Hnf4a*-deficient animals versus controls after irradiation (*P* \< .001) ([Figure 5](#fig5){ref-type="fig"}*C* and *D*). Taken together, our data suggest that the role of HNF4α in epithelial regeneration may not be associated with survival and proliferation of classic *Lgr5*-positive crypt base columnar cells. Given the clear reduction in the number of surviving crypts and BrdU-positive cells in *Hnf4a* mutant animals, this may mean that HNF4α acts at the level of the progenitor cells, which have lost expression of crypt base columnar stem cell markers and cycle very rapidly for a number of cycles until the cells commit to final differentiation.Figure 5***Olfm4* is nearly abolished in *Hnf4a*-deficient intestinal regeneration.** (*A*) RNAscope in situ hybridization of *Lgr5* in *Villin*CreERT2^-^-*Hnf4a*^fl/fl^ and *Villin*CreERT2^+^-*Hnf4a*^fl/fl^ mice at 96 hours after irradiation in small-intestinal tissue. (*B*) qRT-PCR of *Lgr5* in small-intestinal tissue. (*C*) RNAscope in situ hybridization of *Olfm4* in *Villin*CreERT2^-^-*Hnf4a*^fl/fl^ and *Villin*CreERT2^+^-*Hnf4a*^fl/fl^ mice at 96 hours after irradiation in small-intestinal tissue. *Scale bars*: 25 μm. (*D*) qRT-PCR of *Olfm4* in small-intestinal tissue. *Gapdh* is used as a reference gene. n = 8 and 10 per group. Data are plotted as means ± SEM. ∗∗∗∗*P* \< .0001 as calculated by the Student *t* test. Slides were counterstained with hematoxylin. Representative images are shown. mRNA, messenger RNA.

Increased Secretory Lineage Differentiation in *Hnf4a*-Deficient Epithelium {#sec1.5}
---------------------------------------------------------------------------

We next examined the effect of the loss of HNF4α on epithelial cell differentiation during the repair process after irradiation. We observed an increased differentiation toward the secretory lineages in *Hnf4a* mutant epithelium as previously described.[@bib26]^,^[@bib27] Periodic acid--Schiff staining showed increased numbers of goblet cells in mutant animals versus controls ([Figure 6](#fig6){ref-type="fig"}*A* and *B*). This correlated with increased expression of *Muc2*, the major mucin expressed by goblet cells ([Figure 6](#fig6){ref-type="fig"}*C*). Immunohistochemistry for the Paneth cell marker lysozyme showed an increased number of Paneth cells ([Figure 6](#fig6){ref-type="fig"}*D* and *E*). Indeed, gene expression of the Paneth cell--associated Defensin *Defcr1* was increased in *Hnf4a*-deficient animals ([Figure 6](#fig6){ref-type="fig"}*F*). Consistently, expression of sex-determining region Y-box 9 (*Sox9*), a transcription factor associated with Paneth cell differentiation,[@bib28] was increased in *Hnf4a*-deficient animals ([Figure 6](#fig6){ref-type="fig"}*G* and *H*). Thus, the role of HNF4α in restricting secretory lineage differentiation is conserved between homeostasis and epithelial repair.Figure 6***Hnf4a*-deficient intestinal regeneration leads to increased differentiation into the secretory lineage.** (*A*) Periodic acid--Schiff (PAS) staining of *Villin*CreERT2^-^-*Hnf4a*^fl/fl^ and *Villin*CreERT2^+^-*Hnf4a*^fl/fl^ mice at 96 hours after irradiation in small-intestinal tissue. (*B*) Quantification of goblet cells per visual field. (*C*) qRT-PCR of *Muc2* in small-intestinal tissue. (*D*) Lysozyme immunostaining of *Villin*CreERT2^-^-*Hnf4a*^fl/fl^ and *Villin*CreERT2^+^-*Hnf4a*^fl/fl^ mice at 96 hours after irradiation in small-intestinal tissue. (*E*) Quantification of lysozyme-positive cells per crypt. (*F*) qRT-PCR of *Defcr1* in small-intestinal tissue. (*G*) SOX9 immunostaining of *Villin*CreERT2^-^-*Hnf4a*^fl/fl^ and *Villin*CreERT2^+^-*Hnf4a*^fl/fl^ mice at 96 hours after irradiation in small-intestinal tissue. (*H*) qRT-PCR of *Sox9* in small-intestinal tissue. *Gapdh* is used as a reference gene. n = 8 and 10 per group. (*B* and *E*) Data are plotted as means, 1 dot represents 1 mouse, or as means ± SEM. ∗*P* \< .05, ∗∗*P* \< .01, ∗∗∗*P* \< .001, and ∗∗∗∗*P* \< .0001 as calculated by the Student *t* test. Slides were counterstained with hematoxylin. *Scale bars*: (*A* and *G*) 50 μm, and (*D*) 10 μm. Representative images are shown. mRNA, messenger RNA.

Impaired Regeneration in *Hnf4a*^-/-^ Mice Is Associated With Altered Metabolism {#sec1.6}
--------------------------------------------------------------------------------

To further investigate the inability of *Hnf4a*-deficient mice to regenerate upon irradiation, we performed genome-wide gene expression analyses on jejunal tissue samples from irradiated *Villin*Cre*ERT2*^*+*^*Hnf4a*^*fl/fl*^ *Hnf4a* mutant and control *Villin*Cre*ERT2*^*-*^*Hnf4a*^*fl/fl*^ control mice. A principal component analysis showed that the 2 genotypes separated across principal component1 indicated a different response to irradiation ([Figure 7](#fig7){ref-type="fig"}*A*). Interestingly, the jejunal tissue of nonirradiated *Hnf4a*-deficient mice showed no significant alterations in the transcriptional profile compared with nonirradiated wild-type mice (GSE11759). To assess differences between irradiated *Hnf4a*-deficient and control mice, we performed differential gene expression analysis that showed 778 differentially expressed genes (483 up-regulated, 295 down-regulated; fold change \>1.5; analysis of variance *P* \< .05). Among the top 50 up-regulated and down-regulated genes were *Hnf4a*, *Olfm4*, and *Cldn15*, which is an established target of HNF4α ([Figure 7](#fig7){ref-type="fig"}*B*).[@bib29] IPA of the genes that were expressed differentially between irradiated *Villin*Cre*ERT2*^*+*^*Hnf4a*^*fl/fl*^ mutant mice and *Villin*Cre*ERT2*^*-*^*Hnf4a*^*fl/fl*^ controls showed significant changes in pathways related to amino acid and lipid metabolism ([Figure 7](#fig7){ref-type="fig"}*C*). These analyses may suggest that the intestine of irradiated *Hnf4a*-deficient mice is unable to sustain the high metabolic demands of the regeneration process.Figure 7**Metabolic pathways are affected in regenerating *Hnf4a* knockout mice.** (*A*) Principal component analysis of microarray data from small-intestinal tissue of *Villin*CreERT2^-^-*Hnf4a*^fl/fl^ and *Villin*CreERT2^+^-*Hnf4a*^fl/fl^ mice 96 hours after irradiation. (*B*) Heatmap showing the top 50 up-regulated and down-regulated genes from the microarray. (*C*) Log(*P* value) of pathway analysis (KEGG pathways). n = 8 per group. KEGG, Kyoto Encyclopedia of Genes and Genomes; PC, principal component.

Discussion {#sec2}
==========

There are currently no useful in vitro models of intestinal epithelial damage and repair that use primary epithelial cells. An organoid model of irradiation-induced epithelial damage and repair was used previously,[@bib14], [@bib15], [@bib16], [@bib17] however, a careful transcriptional analysis of the repair process has not been performed previously. Here, we describe a model of epithelial regeneration using sublethally irradiated small-intestinal organoids that recapitulates key aspects of epithelial repair after irradiation in vivo. Regeneration is slightly accelerated in organoid culture, with irradiated organoids clustering transcriptionally with time-matched controls after only 96 hours when epithelial repair is still fully ongoing in vivo.[@bib30] This difference may well be related to the presence of luminal content and microbiota and/or, for example, lamina propria (inflammatory) cell types that may alter the epithelial repair process in vivo.[@bib31] Our transcriptional analysis of organoids at different stages of repair identified several established transcriptional regulators of the response to irradiation. HNF4α was identified as a potential novel upstream driver of a damage response program. Our subsequent functional in vitro and in vivo experiments confirmed a clear role for HNF4α in epithelial repair. The fact that *Hnf4a* mutant epithelial cells failed to generate organoids and that organoids in which *Hnf4a* was inducibly deleted failed to propagate in vitro suggests that HNF4α plays a role in epithelial regeneration well beyond damage induced by irradiation.

Interestingly, *HNF4A* has been identified as an ulcerative colitis risk gene in human beings.[@bib32] Mice, in which *Hnf4a* is deleted from the epithelium, are more susceptible to chemically induced colitis,[@bib24] and gradually develop spontaneous ulcerative colitis--like disease as they age.[@bib29] Although the mechanisms of the damage induced in colitis and irradiation are different, the effects of loss of *Hnf4a* on the regenerative response might be similar. HNF4α has been shown to contribute to epithelial barrier function by regulating epithelial tight junctions, which could be an important contributing factor for the development of colitis in mice.[@bib29]^,^[@bib33] However, epithelial barrier function is less likely to account for the phenotype we observed in our irradiation experiments. HNF4α was not required for *Lgr5* expression or maintenance of *Lgr5*^*+*^ cells as judged by in situ hybridization. The profound effect of loss of HNF4α on epithelial repair therefore likely is not linked to *Lgr5*^+^ stem cell survival. On the contrary, the effect on *Olfm4*, which is expressed more broadly than the stem cell compartment, is profound. The molecular function of *Olfm4* is not well understood, but it appears to affect a diverse set of cellular processes, including proliferation, differentiation, apoptosis, adhesion, and innate immunity against bacterial infection.[@bib34]^,^[@bib35] It has been described previously that *Hnf4a*-deficient mice have a higher cell proliferation rate,[@bib26] and dividing cells are more susceptible to irradiation damage. This proliferative state could explain part of the phenotype we observed. Based on analyses of differently expressed genes between irradiated *Hnf4a*-deficient and control mice, genes downstream of HNF4α are affected. Amino acid metabolism and lipid metabolism were among the most affected pathways in the mutant mice. This could be related to the observed regenerative failure in *Hnf4a*-deficient mice. These pathways are pivotal for cellular growth and regeneration upon damage. However, further experiments will be required to address this possibility. Identifying key mediators of regeneration is crucial to determine therapeutic approaches promoting intestinal epithelial regeneration after injury. It should be noted that HNF4α has been shown to bind to approximately 20,000 loci in the mouse genome,[@bib36] affecting target genes that regulate cellular metabolism, function, and differentiation. Therefore, it is likely that multiple mechanisms govern the regenerative response downstream of HNF4α.

Small-molecule inhibitors for HNF4α currently are being investigated,[@bib37], [@bib38], [@bib39] mostly for cancer therapy. If these drugs will be used in clinical trials, our data suggest that caution should be taken when combination therapy with radiotherapy is considered.

Methods {#sec3}
=======

Animals {#sec3.1}
-------

All animal experiments were performed in accordance with the Animal Ethical Committee guidelines of the Academic Medical Center of Amsterdam, The Netherlands (permit ALC102556). A tamoxifen-inducible and intestinal epithelium--specific knockout of *Hnf4a* was obtained by mating *Hnf4a*^*fl/fl*^ mice and *Villin*CreERT2 mice, both on a C57BL/6 background, as previously described.[@bib27]^,^[@bib40] For all experiments, solely male mice were used and littermates were used as controls. For the CreERT2-mediated recombination, mice were given 1 mg tamoxifen (Sigma, St Louis, MO) administered by oral gavage for 5 consecutive days. After 3 weeks, the animals were treated with 14 Gy whole-body γ-irradiation and euthanized 96 hours afterward. Two hours before death all mice received an intraperitoneal injection of 100 mg/kg BrdU (10 mg/mL in phosphate-buffered saline \[PBS\]; Sigma-Aldrich, St Louis, MO). After death, the intestines were harvested, washed with cold PBS, and sectioned into mid, distal, and proximal tissue of the small intestine. For further analysis, the tissues were either snap-frozen or 4% formalin-fixed and embedded in paraffin.

Mouse Intestinal--Crypt Isolation and Organoid Culture {#sec3.2}
------------------------------------------------------

Small-intestinal single crypts were isolated from C57BL/6, *Villin*Cre-*Hnf4a*^*fl/fl*^ and *Villin*CreERT2*-Hnf4a*^*fl/fl*^ mice and cultured in Matrigel (BD Biosciences, Franklin Lakes, NJ). Harvesting and expansion of intestinal organoids was performed as described previously.[@bib13] In brief: crypts were harvested by incubating opened small intestines in PBS containing 2 mmol/L EDTA. The epithelium was released by vigorous shaking and crypts were separated using a 70-μm cell strainer. Single crypts were cultured in ENR medium, containing Advanced Dulbecco's modified Eagle medium (Invitrogen/Thermo Fisher, Waltham, MA) supplemented with 1% penicillin/streptomycin, 1% HEPES buffer, 1% GlutaMAX, 50 ng/mL epidermal growth factor, 20% Noggin-conditioned medium, 10% R-spondin--conditioned medium, 1× B-27 supplement, 1× N-2 supplement (all from Invitrogen), and 1.25 mmol/L n-acetyl cysteine (Sigma). The organoids then were passaged weekly by mechanical disruption in a splitting ratio of 1:3 or 1:4. Cre-mediated recombination of *Hnf4a* in organoids was established by adding 1 μg/mL tamoxifen to the culture medium for 24 hours. Subsequently, the medium with tamoxifen was removed and replaced by standard ENR medium or ENR medium supplemented with 25% WNT3A conditioned medium.

For the in vitro irradiation-induced damage experiments, we treated the organoid cultures 3 days after seeding with various doses of y-radiation ranging between 1 and 10 Gy. Microscopic bright-field images were captured with a Leica DMi8 microscope (Leica, Wetzlar, Germany).

RNA Extraction, qRT-PCR, and Microarray Analysis {#sec3.3}
------------------------------------------------

RNA was extracted from the organoids using the Isolate II RNA Mini Kit (Bioline, London, United Kingdom) following the manufacturer's instructions. The intestinal tissue RNA was extracted with TRI Reagent (Sigma-Aldrich) and RNA clean-up was performed with the RNeasy kit (Qiagen, Hilden, Germany) following the manufacturer's instructions. The qRT-PCR was performed using SybrGreen (Roche, Basel, Switzerland) according to the manufacturer's protocol on a Bio-Rad iCycler (Bio-Rad, Hercules, CA). The primer sequences used are shown in [Table 1](#tbl1){ref-type="table"}.Table 1qPCR Primer SequencesGeneForwardReverse*Apoa1*GAACGAGTACCACACCAGGGATGGGCATCAGACTATGGCG*Cdkn1a*TCCACAGCGATATCCAGACAGGACATCACCAGGATTGGAC*Defcr1*TCAAGAGGCTGCAAAGGAAGAACCCTTTCTGCAGGTTCCATT*Egr1*GAGTCGTTTGGCTGGGATAACCTTCAATCCTCAAGGGGAG*G6pc*CAGTGGTCGGAGACTGGTTCAGATGACGTTCAAACACCGGA*Hnf4a*AAATGTGCAGGTGTTGACCACTCACGCTCCTCCTGAAGAA*Lgr5*TGTGTCAAAGCATTTCCAGCCAGCGTCTTCACCTCCTACC*Mttp*CCAGGACCTCACTGCTTCTTGCCAGTTGTGTGACCGCTA*Muc2*GAAGCCAGATCCCGAAACCAGAATCGGTAGACATCGCCGT*Nr1h3*GGGAAACGCGACAGTTTTGGACTCCGTTGCAGAATCAGGA*Nr1i3*GGAGCGGCTGTGGAAATATTGCATTCCATCTTGTAGCAAAGAGGCCCA*Olfm4*AACATCACCCCAGGCTACAGTGTCCACAGACCCAGTGAAA*Pklr*CAGTATGGAAGGGCCAGCAGTGGGAGAAGTTGAGTCGTGC*Sox9*AGGAAGCTGGCAGACCAGTACTCCTCCACGAAGGGTCTCT

To confirm the knockout of *Hnf4a* after tamoxifen induction, a qRT-PCR was performed using primers located in exons 4 and 5, as well as exons 3 and 5, as described by Cattin et al.[@bib27]

For the microarrays, RNA was amplified using a TotalPrep RNA amplification kit for Illumina (Illumina, San Diego, CA), and labeled using a complementary RNA labeling kit for Illumina Arrays (Illumina), followed by hybridization with Illumina Ref8 v2.0 mouse slides. Expression profiles were deposited in the following GEO repositories: GSE141515 (organoid irradiation) and GSE141518 (*Hnf4a* knockout irradiation). Initial normalization was performed using Genome studio software (v2.0; Illumina). Further analysis was performed with the R2 Bioinformatic platform (<http://r2.amc.nl>; AMC, Amsterdam, The Netherlands), and IPA software (version 2.4; Qiagen).

Immunohistochemistry and TUNEL Staining {#sec3.4}
---------------------------------------

For histology, sections (5 μm) were deparaffinized with xylene and rehydrated in a graded series of ethanol.

For periodic acid--Schiff staining, slides were incubated for 30 minutes in 0.5% periodic acid and for 30 minutes in Schiff's solution (VWR Chemicals, Radnor, PA).

For immunohistochemistry, endogenous peroxidase activity was blocked with 3% H~2~O~2~ in PBS. For antigen retrieval, tissue was cooked in 0.01 mol/L sodium citrate solution (pH 6.0) for 20 minutes or alternatively in 0.1 mol/L sodium EDTA (pH 9.0) for 20 minutes. Nonspecific binding was prevented by incubation with an avidin and biotin blocking solution (Vector Laboratories, Burlingame, CA). Tissues sections were incubated overnight with a primary antibody. Subsequently, the sections were incubated with a biotinylated secondary antibody for 10 minutes, followed by a 10 minutes incubation with a LSAB2 streptavidin--horseradish peroxidase (K1016; DAKO, Agilent, Santa Clara, CA), and horseradish peroxidase detection with Vector NovaRED substrate (SK-4800; Brunschwig, Amsterdam, The Netherlands). Mayer's hematoxylin (Sigma-Aldrich) was used as nuclear counterstain. The following antibodies were used: anti-HNF4α (sc-6556; Santa Cruz Biotechnology, Dallas, TX), mouse anti-BrdU (BMC9318; Roche), rabbit anti-activated caspase 3 (9661S; Cell Signaling Technology, Danvers, MA), rabbit antilysozyme (A0099; DAKO), and rabbit anti-SOX9 (AB5535; Millipore, Burlington, MA).

For TUNEL staining, the in situ cell death detection kit from Roche was used (reference number: 11684 817 910) according to the manufacturer's instructions.

Images were captured with an Olympus BX51 (Olympus, Tokyo, Japan) microscope.

In Situ Hybridization {#sec3.5}
---------------------

RNAscope in situ hybridization (Advanced Cell Diagnostics, Biotechne, Newark, CA) was performed according to the Formalin-Fixed Paraffin-Embedded Sample Preparation and Pretreatment for RNAscope 2.5 assay and RNAscope 2.5 HD Detection Reagent--RED protocols provided by the manufacturer. In brief, slides were deparaffinized, treated with heat antigen retrieval and protease, followed by a series of hybridizations with the target-specific probes and amplifiers. All components from the protocol were provided in RNAscope pretreatment reagents (322300 and 322000) and RNAscope 2.5 HD detection reagent (322350). The following probes were used: mm_Olfm4 (311831) and mm_Lgr5 (312171).

Flow Cytometry {#sec3.6}
--------------

For analysis of apoptosis, small-intestinal organoids were fixed and stained with anti--Annexin V--fluorescein isothiocyanate (560534; BD Pharmingen, Franklin Lakes, NJ). Expression was analyzed by flow cytometry using a FACS Fortessa (BD Bioscience Franklin Lakes, NJ) with FlowJo software (Treestar, Inc, Ashland, OR). For analysis of proliferation, small-intestinal organoids were incubated with 10 mmol/L 5-ethynyl-2'-deoxyuridine (EdU) for 2 hours at 37°C. Subsequently, we used the Click-iT EdU Alexa Fluor 647 Flow Cytometry Assay Kit (ThermoFisher Scientific) according to the manufacturer's manual. Cells were double-stained with propidium iodide to determine the cell-cycle phase. EdU-positive (S-phase) cells were quantified by flow cytometry on dissociated organoid cultures using a FACS Fortessa (BD Bioscience) with FlowJo software (Treestar, Inc). Dead cells were excluded with propidium iodide.

Statistical Analysis {#sec3.7}
--------------------

Data are presented as means and SEM. The Student *t* test was used to analyze data with 2 groups. One-way analysis of variance with the Tukey multiple comparison test was performed for data with more than 2 groups. For statistical analysis, GraphPad Prism (version 7; GraphPad Software, Inc, La Jolla, CA) was used. A *P* value less than .05 was considered statistically significant.
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